We anticipate that further studies on the sensitivity and specificity of molecules other than HE4 in clinical trials will be undertaken to aid in the diagnosis, treatment and prognostic monitoring of early-stage ovarian cancer. Here, WFDC2 is linked to ovarian carcinoma.